Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00011141 · ClinicalTrials.gov registry record · NA
Lactobacillus Plantarum as Therapy for NK-T Cell Deficiency
A NA study, sponsored by National Center for Research Resources (NCRR).
- Completed
- Registry status
- NA
- Development phase
NCT00011141 is a NA study that has completed, run by National Center for Research Resources (NCRR).
The verdict
NCT00011141, a NA study, has completed, sponsored by National Center for Research Resources (NCRR).
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
The etiology of immune-mediated diabetes mellitus (IMD) remains unclear. However, previous studies indicate that autoimmunity may be a result of dysfunction of natural killer T cells (NK-T cells). Newly diagnoses patients with IMD have been shown in our laboratory to have significantly lower NK-T cells than normal controls. Other studies have shown that oral administration of lactobacillus can boost NK-T cell activity in children with HIV without side effects. Our objective is to evaluate the effect of lactobacillus administration on NK-T cell activity in patients with IMD
Interventions
- DRUG Oral lactobacillus administration
Trial Details
| Field | Value |
|---|---|
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00011141
The ClinicalTrials.gov registry entry for NCT00011141 describes a study currently listed as completed, categorized as NA. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is National Center for Research Resources (NCRR), which has 94 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Oral lactobacillus administration is the first listed.
NCT00011141 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00011141 about?
NCT00011141 is a clinical study titled "Lactobacillus Plantarum as Therapy for NK-T Cell Deficiency". The etiology of immune-mediated diabetes mellitus (IMD) remains unclear. However, previous studies indicate that autoimmunity may be a result of dysfunction of natural killer T cells (NK-T cells). Newly diagnoses patients with IMD have been shown in our laboratory to have significantly lower NK-T ce...
What is the current status of trial NCT00011141?
This trial is currently completed. It is a NA study.
What interventions are being tested in trial NCT00011141?
The interventions under investigation include: Oral lactobacillus administration (DRUG).
Who is sponsoring clinical trial NCT00011141?
This trial is sponsored by National Center for Research Resources (NCRR), which has 94 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.